vs

Side-by-side financial comparison of IF Bancorp, Inc. (IROQ) and SHOULDER INNOVATIONS, INC. (SI). Click either name above to swap in a different company.

SHOULDER INNOVATIONS, INC. is the larger business by last-quarter revenue ($11.8M vs $7.3M, roughly 1.6× IF Bancorp, Inc.). IF Bancorp, Inc. runs the higher net margin — 18.1% vs -74.3%, a 92.4% gap on every dollar of revenue. IF Bancorp, Inc. produced more free cash flow last quarter ($1.7M vs $-11.4M).

U.S. Bancorp is an American multinational banking institution headquartered in Minneapolis, Minnesota and incorporated in Delaware. It is the 5th-largest bank in the United States as of 2025. As the largest bank in the Midwestern United States, it is considered systemically important by the Financial Stability Board. It is the parent company of its primary operating entity, U.S. Bank National Association, which does business as U.S. Bank. The company provides banking, investment, mortgage, tr...

Shoulder Innovations, Inc. is a medical technology firm specializing in design, development, and commercialization of innovative orthopedic devices for shoulder replacement surgery. Its products reduce surgical complications, improve patient outcomes, and are sold to orthopedic surgeons and healthcare providers across North America and Western Europe.

IROQ vs SI — Head-to-Head

Bigger by revenue
SI
SI
1.6× larger
SI
$11.8M
$7.3M
IROQ
Higher net margin
IROQ
IROQ
92.4% more per $
IROQ
18.1%
-74.3%
SI
More free cash flow
IROQ
IROQ
$13.1M more FCF
IROQ
$1.7M
$-11.4M
SI

Income Statement — Q2 FY2026 vs Q3 FY2025

Metric
IROQ
IROQ
SI
SI
Revenue
$7.3M
$11.8M
Net Profit
$1.3M
$-8.7M
Gross Margin
76.2%
Operating Margin
24.9%
-65.0%
Net Margin
18.1%
-74.3%
Revenue YoY
16.8%
Net Profit YoY
8.9%
EPS (diluted)
$0.41
$-0.64

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IROQ
IROQ
SI
SI
Q4 25
$7.3M
Q3 25
$7.3M
$11.8M
Q2 25
$6.9M
$11.0M
Q1 25
$6.4M
Q4 24
$6.3M
Q3 24
$6.2M
Q2 24
$5.7M
Q1 24
$5.4M
Net Profit
IROQ
IROQ
SI
SI
Q4 25
$1.3M
Q3 25
$1.4M
$-8.7M
Q2 25
$1.4M
$-19.2M
Q1 25
$1.0M
Q4 24
$1.2M
Q3 24
$633.0K
Q2 24
$431.0K
Q1 24
$708.0K
Gross Margin
IROQ
IROQ
SI
SI
Q4 25
Q3 25
76.2%
Q2 25
76.2%
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Operating Margin
IROQ
IROQ
SI
SI
Q4 25
24.9%
Q3 25
26.0%
-65.0%
Q2 25
29.1%
-53.2%
Q1 25
21.7%
Q4 24
26.8%
Q3 24
13.7%
Q2 24
9.3%
Q1 24
17.6%
Net Margin
IROQ
IROQ
SI
SI
Q4 25
18.1%
Q3 25
19.0%
-74.3%
Q2 25
21.0%
-174.3%
Q1 25
15.8%
Q4 24
19.4%
Q3 24
10.2%
Q2 24
7.6%
Q1 24
13.1%
EPS (diluted)
IROQ
IROQ
SI
SI
Q4 25
$0.41
Q3 25
$0.43
$-0.64
Q2 25
$0.48
$-165.53
Q1 25
$0.31
Q4 24
$0.38
Q3 24
$0.20
Q2 24
$0.15
Q1 24
$0.22

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IROQ
IROQ
SI
SI
Cash + ST InvestmentsLiquidity on hand
$8.8M
$54.9M
Total DebtLower is stronger
Stockholders' EquityBook value
$87.4M
$147.8M
Total Assets
$830.4M
$177.8M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IROQ
IROQ
SI
SI
Q4 25
$8.8M
Q3 25
$8.0M
$54.9M
Q2 25
$20.1M
$27.1M
Q1 25
$8.9M
Q4 24
$5.9M
Q3 24
$7.8M
Q2 24
$9.6M
Q1 24
$16.1M
Stockholders' Equity
IROQ
IROQ
SI
SI
Q4 25
$87.4M
Q3 25
$84.5M
$147.8M
Q2 25
$81.8M
$-78.2M
Q1 25
$78.9M
Q4 24
$75.9M
Q3 24
$78.8M
Q2 24
$73.9M
Q1 24
$72.4M
Total Assets
IROQ
IROQ
SI
SI
Q4 25
$830.4M
Q3 25
$862.3M
$177.8M
Q2 25
$887.7M
$77.8M
Q1 25
$879.1M
Q4 24
$885.1M
Q3 24
$893.4M
Q2 24
$887.7M
Q1 24
$905.0M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IROQ
IROQ
SI
SI
Operating Cash FlowLast quarter
$1.8M
$-8.6M
Free Cash FlowOCF − Capex
$1.7M
$-11.4M
FCF MarginFCF / Revenue
23.7%
-96.7%
Capex IntensityCapex / Revenue
0.9%
23.9%
Cash ConversionOCF / Net Profit
1.36×
TTM Free Cash FlowTrailing 4 quarters
$9.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IROQ
IROQ
SI
SI
Q4 25
$1.8M
Q3 25
$-539.0K
$-8.6M
Q2 25
$6.8M
$-11.3M
Q1 25
$1.8M
Q4 24
$-155.0K
Q3 24
$2.2M
Q2 24
$2.3M
Q1 24
$19.0K
Free Cash Flow
IROQ
IROQ
SI
SI
Q4 25
$1.7M
Q3 25
$-582.0K
$-11.4M
Q2 25
$6.5M
$-13.6M
Q1 25
$1.8M
Q4 24
$-226.0K
Q3 24
$2.1M
Q2 24
$2.0M
Q1 24
$-67.0K
FCF Margin
IROQ
IROQ
SI
SI
Q4 25
23.7%
Q3 25
-7.9%
-96.7%
Q2 25
95.1%
-123.4%
Q1 25
28.2%
Q4 24
-3.6%
Q3 24
33.6%
Q2 24
35.7%
Q1 24
-1.2%
Capex Intensity
IROQ
IROQ
SI
SI
Q4 25
0.9%
Q3 25
0.6%
23.9%
Q2 25
3.5%
21.0%
Q1 25
0.4%
Q4 24
1.1%
Q3 24
1.2%
Q2 24
4.3%
Q1 24
1.6%
Cash Conversion
IROQ
IROQ
SI
SI
Q4 25
1.36×
Q3 25
-0.39×
Q2 25
4.69×
Q1 25
1.81×
Q4 24
-0.13×
Q3 24
3.42×
Q2 24
5.30×
Q1 24
0.03×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons